These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25030683)

  • 21. [Anti-cancer activity of metformin: new perspectives for an old drug].
    Beck E; Scheen AJ
    Rev Med Suisse; 2010 Sep; 6(260):1601-7. PubMed ID: 20853715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
    Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between metformin use and risk of prostate cancer and its grade.
    Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
    J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis.
    Campbell JM; Bellman SM; Stephenson MD; Lisy K
    Ageing Res Rev; 2017 Nov; 40():31-44. PubMed ID: 28802803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin and breast cancer risk: a meta-analysis and critical literature review.
    Col NF; Ochs L; Springmann V; Aragaki AK; Chlebowski RT
    Breast Cancer Res Treat; 2012 Oct; 135(3):639-46. PubMed ID: 22847511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
    BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes.
    Han K; Pintilie M; Lipscombe LL; Lega IC; Milosevic MF; Fyles AW
    Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):507-12. PubMed ID: 26721670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
    Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 31. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
    Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
    Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
    Haukka J; Niskanen L; Auvinen A
    Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis.
    Hwang IC; Park SM; Shin D; Ahn HY; Rieken M; Shariat SF
    Asian Pac J Cancer Prev; 2015; 16(2):595-600. PubMed ID: 25684493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
    Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
    Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
    J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
    Lee JH; Kim TI; Jeon SM; Hong SP; Cheon JH; Kim WH
    Int J Cancer; 2012 Aug; 131(3):752-9. PubMed ID: 21913184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and prostate cancer mortality: a meta-analysis.
    Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
    Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
    Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
    Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.
    Yin M; Zhou J; Gorak EJ; Quddus F
    Oncologist; 2013; 18(12):1248-55. PubMed ID: 24258613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.